1. Antibiotic / Antimicrobial Resistance (AR / AMR)—About Antimicrobial Resistance. Centers for Disease Control and Prevention (CDC): U.S. Department of Health & Human Services, 2010. Retrieved 2 Sept 2019, from https://www.cdc.gov/drugresistance/about.html.
2. Acinetobacter in Healthcare Settings—General information about Acinetobacter. Centers for Disease Control and Prevention (CDC): U.S. Department of Health & Human Services, 2010. Retrieved 19 June 2018, from https://www.cdc.gov/hai/organisms/acinetobacter.html.
3. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.
4. El-Bassuony NA-MMM. Phenotypic and genetic characterization of multidrug resistant nosocomial isolates of acinetobacter calcoaceticus–baumannii complex from intensive care units in Mansoura University main hospital. Mansoura: Faculty of Medicine, Mansoura University; 2016.
5. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333–41.